Boehringer Seeks To Divide Claims In AWP Case

By Erin Coe

Law360, New York (March 03, 2010, 4:48 PM ET) -- Boehringer Ingelheim Corp. is seeking to split up for trial certain claims against it in a case alleging it defrauded Medicare and Medicaid programs by reporting inflated drug prices.

Boehringer and sister company Boehringer Ingelheim Pharmaceuticals Inc. on Monday asked the U.S. District Court for the District of Massachusetts, which is overseeing consolidated multidistrict litigation brought by the U.S. government and relator Ven-A-Care of the Florida Keys Inc., to bifurcate certain corporate veil-piercing claims against them from underlying False Claims Act allegations against them and unit...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles